USA flag logo/image

An Official Website of the United States Government

ENZYME ASSAY CHIPS FOR APOPTOSIS DISCOVERY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
60020
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
CA096200
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
REACTION BIOLOGY CORPORATION
ONE GREAT VALLEY PARKWAY MALVERN, PA -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: ENZYME ASSAY CHIPS FOR APOPTOSIS DISCOVERY
Agency: HHS
Contract: 1R43CA096200-01
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION (provided by applicant): While genomic and phenotypic analysis has reached a massive scale with the widespread use of DNA chips and arrays, the world of proteomics remains hindered by the complexity of proteins and the difficulty of their analysis. We seek to create an affordable and easily implementable proteomic tool in the form of low cost "enzyme assay chips" that allow evaluation of enzyme activities at the level of 400 reactions per cm2 or up to 4,000 reactions per slide. Each reaction will be tailored for detection of a specific enzyme activity in the presence of individualized activators, cofactors, and inhibitors of the target enzyme of assay at each sensing element. A novel microfluidics technology has been patented and tested for this application. Specific Aim 1 (design driven) will define the operational/quality control conditions for rapid sensing of enzyme activities on high-density chips using less than 100,000 cells. This aim will also utilize purified enzymes to test and calibrate the enzyme activity-sensing surface. Specific Aim 2 (hypothesis driven) will seek to create an "apoptosis" chip to map apoptotic pathways in cells subjected to several chemical agents. We hypothesize that sub-critical levels of several apoptotic inducers will interact to cause a marked change in the readout of the chip. Specific Aim 3 (design/hypothesis driven) seeks to create de-convolution software to predict hidden variables (concentrations of numerous enzymes) delivered to the sensor surface. We hypothesize that complex patterns of enzyme sensing can be de-convoluted for over 10 enzyme activities in a sample for every 100 enzyme determinations even in the presence of enzyme cross-talk. Phase I activities will lead toward establishing chip chemistries for a commercialized chip to aid in apoptosis, cancer, drug toxicity research, as well as, secondary drug testing and industrial bioreactor monitoring. This will enable Phase II activities that will focus on the development of an automated, yet affordable bench top technology for the utilization. PROPOSED COMMERCIAL APPLICATION: An enzyme assay chip technology will be validated for the assay of numerous intracellular proteases using extremely small cellular or biological samples placed on a sensing chip. This technology can have research, medical, and industrial uses with respoect to the monitoring of intracellular enzyme states and identifying potential drug targets.

Principal Investigator:

Haiching Ma
6107220247
HAICHING@MOREWOODMOLECULAR.COM

Business Contact:

Patricia Rogan
4126972920
PAT@MOREWOODMOLECULAR.COM
Small Business Information at Submission:

MOREWOOD MOLECULAR SCIENCES, INC
MOREWOOD MOLECULAR SCIENCES, INC 5001 CENTRE AVE PITTSBURGH, PA 15213

EIN/Tax ID: 251889524
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No